These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8410885)

  • 21. Is the routine check nephrostogram following percutaneous antegrade ureteric stent placement necessary?
    Soh KC; Tay KH; Tan BS; Mm Htoo A; Hg Lo R; Lin SE
    Cardiovasc Intervent Radiol; 2008; 31(3):604-9. PubMed ID: 17710479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Management of ureteric sticture via a percutaneous double J stent implantation--description of 2 cases].
    Wojtal K; Miazga M; Sojka M; Szajner M; Szczerbo-Trojanowska M
    Przegl Lek; 2012; 69(7):402-5. PubMed ID: 23276049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors in the prediction of long-term patency of Resonance metallic ureteric stent in malignant ureteric obstruction.
    Ho BSH; Chiu PKF; Lam W; Wong JHF; Wong CKW; Lai TCT; Tsang CF; Ng ATL; Chan CK; Ma WK; Ng CF; Tsu JHL
    BJUI Compass; 2020 May; 1(2):74-81. PubMed ID: 35474710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wire-reinforced ureteral stents to rescue from nephrostomy tube in extrinsic ureteral obstruction.
    Dauw CA; Faerber GJ; Hollingsworth JM; Wolf JS
    Can J Urol; 2015 Jun; 22(3):7806-10. PubMed ID: 26068630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antegrade double J ureteral stenting for ureteric strictures: use of silicone stents.
    Hoe JW
    Australas Radiol; 1989 Nov; 33(4):385-9. PubMed ID: 2633742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined antegrade and retrograde access to difficult ureters: revisiting the rendezvous technique.
    Keoghane SR; Deverill SJ; Woodhouse J; Shennoy V; Johnston T; Osborn P
    Urolithiasis; 2019 Aug; 47(4):383-390. PubMed ID: 29959479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. To tube or not to tube? Utilising a tubeless antegrade ureteric stenting system in a tertiary referral hospital.
    Looney AT; Daly PJA; Cullen IM; MacMahon P; Kelly IMG
    Ir J Med Sci; 2019 Feb; 188(1):283-288. PubMed ID: 29696559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retrograde stenting for obstruction of the renal transplant ureter.
    Gerrard ER; Burns JR; Young CJ; Urban DA; Hammontree LN; El-Galley R; Kolettis PN
    Urology; 2005 Aug; 66(2):256-60; discussion 260. PubMed ID: 16098351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastrointestinal cancer and bilateral hydronephrosis resulted in a high risk of ureteral stent failure.
    Ohtaka M; Kawahara T; Takamoto D; Mochizuki T; Hattori Y; Teranishi JI; Makiyama K; Miyoshi Y; Yumura Y; Yao M; Uemura H
    BMC Urol; 2018 May; 18(1):35. PubMed ID: 29739370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ureteric obstruction in familial adenomatous polyposis-associated desmoid disease.
    Joyce M; Mignanelli E; Church J
    Dis Colon Rectum; 2010 Mar; 53(3):327-32. PubMed ID: 20173481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Initial experience with the resonance metallic stent for antegrade ureteric stenting.
    Wah TM; Irving HC; Cartledge J
    Cardiovasc Intervent Radiol; 2007; 30(4):705-10. PubMed ID: 17508238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Percutaneous urinary drainage and ureteric stenting in malignant disease.
    Allen DJ; Longhorn SE; Philp T; Smith RD; Choong S
    Clin Oncol (R Coll Radiol); 2010 Nov; 22(9):733-9. PubMed ID: 20728326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extra-anatomic stents in ureteric obstruction: experience and complications.
    Minhas S; Irving HC; Lloyd SN; Eardley I; Browning AJ; Joyce AD
    BJU Int; 1999 Nov; 84(7):762-4. PubMed ID: 10532967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of full-length metallic stents in malignant ureteral obstruction.
    Abbasi A; Wyre HW; Ogan K
    J Endourol; 2013 May; 27(5):640-5. PubMed ID: 23237309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Galdakao-modified Valdivia position in endoscopic management of malignant ureteric obstruction.
    Emam A; Elmoazen M; Shabayek M; Zriek AM; Gad HH
    Int Urol Nephrol; 2022 Mar; 54(3):463-468. PubMed ID: 35084651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of a segmental thermoexpandable metal alloy stent in the management of malignant ureteric obstruction: a single centre experience in the UK.
    Zaman F; Poullis C; Bach C; Moraitis K; Junaid I; Buchholz N; Masood J
    Urol Int; 2011; 87(4):405-10. PubMed ID: 22005456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The management of bilateral ureteric obstruction and renal failure in advanced prostate cancer.
    Paul AB; Love C; Chisholm GD
    Br J Urol; 1994 Nov; 74(5):642-5. PubMed ID: 7827817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retrograde pyelography predicts retrograde ureteral stenting failure and reduces unnecessary stenting trials in patients with advanced non-urological malignant ureteral obstruction.
    Kim SH; Park B; Joo J; Joung JY; Seo HK; Chung J; Lee KH
    PLoS One; 2017; 12(9):e0184965. PubMed ID: 28931043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [LAPAROSCOPIC PYELOPLASTY WITH ANTEGRADE URETERAL STENTING].
    Guliev BG
    Urologiia; 2015; (3):60-3. PubMed ID: 26390562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ureteral metal stents: 10-year experience with malignant ureteral obstruction treatment.
    Liatsikos EN; Karnabatidis D; Katsanos K; Kallidonis P; Katsakiori P; Kagadis GC; Christeas N; Papathanassiou Z; Perimenis P; Siablis D
    J Urol; 2009 Dec; 182(6):2613-7. PubMed ID: 19836807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.